by VirTrial | Oct 23, 2019 | Blog
Clinical research sites have a lot to gain from incorporating decentralized clinical trials into their practices. Though the technology is commonly touted as a benefit to sponsors and patients, there are just as many advantages for research sites. As the addition of...
by VirTrial | Oct 10, 2019 | Press Releases
Scottsdale, AZ (October 10, 2019) – VirTrial today announced an alliance with Pratia, the largest network of clinical research centers in Europe. All Pratia research centers have completed VirTrial’s Virtual Trial Capable training, making them the first site...
by VirTrial | Oct 9, 2019 | Press Releases
Scottsdale, AZ (October 9, 2019) – VirTrial has been awarded an FDA-approved hybrid decentralized clinical trial (DCT) with Hope Biosciences. The study provides Hope Biosciences’ autologous, adipose-derived culture-expanded mesenchymal stem cells (HB-adMSC’s)...
